Minims Artificial Tears 0.35% w/w + 0.44% w/w Eye Drops, Solution Ireland - English - HPRA (Health Products Regulatory Authority)

minims artificial tears 0.35% w/w + 0.44% w/w eye drops, solution

bausch health ireland limited - sodium chloride; hydroxyethylcellulose - eye drops, solution - 0.35% w/w + 0.44 percent weight/weight - other antiinfectives; sodium borate

Brolene 0.1% w/v Eye Drops Solution Ireland - English - HPRA (Health Products Regulatory Authority)

brolene 0.1% w/v eye drops solution

clonmel healthcare ltd - propamidine isetionate - eye drops, solution - other antiinfectives; propamidine

Brolene 0.15 % w/w Eye Ointment Ireland - English - HPRA (Health Products Regulatory Authority)

brolene 0.15 % w/w eye ointment

clonmel healthcare ltd - dibrompropamidine isetionate - eye ointment - other antiinfectives; dibrompropamidine

Minims Artificial Tears 0.35% w/w + 0.44% w/w Eye Drops, Solution Ireland - English - HPRA (Health Products Regulatory Authority)

minims artificial tears 0.35% w/w + 0.44% w/w eye drops, solution

bausch + lomb ireland limited - sodium chloride; hydroxyethylcellulose - eye drops, solution - other antiinfectives; sodium borate

Minims povidone iodine 5% eye drops 0.4ml unit dose United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

minims povidone iodine 5% eye drops 0.4ml unit dose

bausch & lomb uk ltd - povidone-iodine - eye drops - 50mg/1ml

Brolene New Zealand - English - Medsafe (Medicines Safety Authority)

brolene

pharmacy retailing (nz) ltd t/a healthcare logistics - propamidine isetionate 0.1%{relative} - eye drops, solution - 0.1 % - active: propamidine isetionate 0.1%{relative} excipient: ammonium chloride benzalkonium chloride sodium chloride sodium hydroxide water for injection

Brolene New Zealand - English - Medsafe (Medicines Safety Authority)

brolene

sanofi-aventis new zealand limited - dibrompropamidine isetionate 0.15%;   - eye ointment - 0.15 % - active: dibrompropamidine isetionate 0.15%  

OFLOX Israel - English - Ministry of Health

oflox

abbvie biopharmaceuticals ltd, israel - ofloxacin - ophthalmic solution - ofloxacin 0.3 % - ofloxacin - ofloxacin - for the treatment of external ocular infections caused by ofloxacin sensitive organisms.

CILOXAN Israel - English - Ministry of Health

ciloxan

novartis israel ltd - ciprofloxacin as hydrochloride - solution - ciprofloxacin as hydrochloride 3 mg/ml - ciprofloxacin - ciprofloxacin - corneal ulcers and conjunctivitis caused by susceptible gram positive and gram negative microorganisms for adults and pediatric patients above the age of 1 year. for localized or diffuse otitis externa accompanied by a strong inflammatory reaction and of which the strains are susceptible to ciprofloxacin, and for the acute flare-up of a chronic otitis media. in this case, a mucopurulent secretion comes through the perforated eardrum. pseudomonas aeruginosa is one of the organisms most likely to be found in this case. also in other infections of the ear in which pseudomonas aeruginosa and/or other susceptible strains may be demonstrated or suspected (for example with suppurating tympanic tubes), ciloxan can be used under the strict supervision of an ear specialist. it must be understood that this is not a routine treatment and that improper use must be avoided.

UFEXIL 2 MG/ML Israel - English - Ministry of Health

ufexil 2 mg/ml

naveh pharma ltd - ciprofloxacin as lactate 2 mg/ml - solution for infusion - ciprofloxacin - broad spectrum antibiotic for infections caused by ciprofloxacin sensitive pathogens: invasive infections of the external ear. treatment of acute pulmonary exacerbation of cystic fibrosis associated with p.aeroginosa infections in pediatric patients aged 5-17 years.